Direxion Daily S&P Biotech Bear 1X ETF
On Tuesday, MKM Partners downgraded HEXO to “neutral” from “buy.” MKM Partners lowered its target price from 5 Canadian dollars to 1.50 Canadian dollars.
Cannabis stocks see dark clouds looming. The week ending on October 11 was disastrous for the sector. Hexo stock fell after it withdrew its fiscal 2020 outlook.